Healthcare >> CEO Interviews >> March 18, 2002
JONATHAN ROSS GOODMAN is President and Chief Executive Officer of
Paladin Labs Inc. He founded publicly traded Paladin Labs in 1996 at 28
after having obtained a Law degree and an MBA at McGill University and
having studied at the London School of Economics. Paladin's strategy is
to acquire, license and market innovative specialty pharmaceuticals for
the Canadian market. The Top 40 Under 40 recipient is the youngest
member of the Board of Directors of Canada's Research Based
Pharmaceutical Companies, finds time for charitable endeavors and
teaches a course on pharmaceutical entrepreneurship to McGill MBA
students. This year he was named Quebec Entrepreneur of the Year in the
health care life sciences field by Ernst &Young. Profile
TWST: Could we begin with an overview and summary of PaladinLabs?
Mr. Goodman: Paladin Labs Inc. is a specialty pharmaceutical
company focused on acquiring or in-licensing